Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2023-06-05

Clinical Trial Update: Effects of Walkasins on Gait Speed of Individuals With Mild Cognitive Impairments [NA]

View source ↗

Summary

A completed clinical trial evaluating the effects of Walkasins on gait speed in individuals with mild cognitive impairment and cognitive decline.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Walkasins

Snippet

Sponsor: RxFunction Inc. | Conditions: Mild Cognitive Impairment, Cognitive Decline | NA | Status: COMPLETED | Results posted: 2023-06-05